nodes	percent_of_prediction	percent_of_DWPC	metapath
Ciclesonide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0427	0.291	CbGbCtD
Ciclesonide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0397	0.271	CbGbCtD
Ciclesonide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0182	0.124	CbGbCtD
Ciclesonide—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0179	0.122	CbGbCtD
Ciclesonide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0167	0.114	CbGbCtD
Ciclesonide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0114	0.0777	CbGbCtD
Ciclesonide—Weight increased—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.0027	CcSEcCtD
Ciclesonide—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.00227	0.00266	CcSEcCtD
Ciclesonide—Back pain—Topotecan—peripheral nervous system neoplasm	0.00227	0.00266	CcSEcCtD
Ciclesonide—Infestation NOS—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00265	CcSEcCtD
Ciclesonide—Infestation—Alitretinoin—peripheral nervous system neoplasm	0.00226	0.00265	CcSEcCtD
Ciclesonide—Back pain—Tretinoin—peripheral nervous system neoplasm	0.00225	0.00264	CcSEcCtD
Ciclesonide—Back pain—Isotretinoin—peripheral nervous system neoplasm	0.00225	0.00264	CcSEcCtD
Ciclesonide—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.00223	0.00262	CcSEcCtD
Ciclesonide—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.00257	CcSEcCtD
Ciclesonide—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00219	0.00257	CcSEcCtD
Ciclesonide—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00219	0.00257	CcSEcCtD
Ciclesonide—Pharyngitis—Dactinomycin—peripheral nervous system neoplasm	0.00217	0.00254	CcSEcCtD
Ciclesonide—Dysphonia—Epirubicin—peripheral nervous system neoplasm	0.00214	0.00252	CcSEcCtD
Ciclesonide—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00214	0.00251	CcSEcCtD
Ciclesonide—Epistaxis—Alitretinoin—peripheral nervous system neoplasm	0.00213	0.0025	CcSEcCtD
Ciclesonide—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.00212	0.00248	CcSEcCtD
Ciclesonide—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00206	0.00241	CcSEcCtD
Ciclesonide—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00206	0.00241	CcSEcCtD
Ciclesonide—Cough—Topotecan—peripheral nervous system neoplasm	0.00205	0.0024	CcSEcCtD
Ciclesonide—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00204	0.00239	CcSEcCtD
Ciclesonide—Cough—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00238	CcSEcCtD
Ciclesonide—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00238	CcSEcCtD
Ciclesonide—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00202	0.00238	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.00202	0.00236	CcSEcCtD
Ciclesonide—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00201	0.00236	CcSEcCtD
Ciclesonide—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00236	CcSEcCtD
Ciclesonide—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00236	CcSEcCtD
Ciclesonide—Cough—Melphalan—peripheral nervous system neoplasm	0.002	0.00235	CcSEcCtD
Ciclesonide—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.002	0.00234	CcSEcCtD
Ciclesonide—Chest pain—Topotecan—peripheral nervous system neoplasm	0.002	0.00234	CcSEcCtD
Ciclesonide—Dysphonia—Doxorubicin—peripheral nervous system neoplasm	0.00198	0.00233	CcSEcCtD
Ciclesonide—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00198	0.00232	CcSEcCtD
Ciclesonide—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00198	0.00232	CcSEcCtD
Ciclesonide—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00198	0.00232	CcSEcCtD
Ciclesonide—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00198	0.00232	CcSEcCtD
Ciclesonide—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00195	0.00229	CcSEcCtD
Ciclesonide—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00194	0.00228	CcSEcCtD
Ciclesonide—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00194	0.00227	CcSEcCtD
Ciclesonide—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.00227	CcSEcCtD
Ciclesonide—Infection—Topotecan—peripheral nervous system neoplasm	0.0019	0.00223	CcSEcCtD
Ciclesonide—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00189	0.00221	CcSEcCtD
Ciclesonide—Infection—Tretinoin—peripheral nervous system neoplasm	0.00189	0.00221	CcSEcCtD
Ciclesonide—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00187	0.00219	CcSEcCtD
Ciclesonide—Ulcer—Epirubicin—peripheral nervous system neoplasm	0.00187	0.00219	CcSEcCtD
Ciclesonide—Infection—Melphalan—peripheral nervous system neoplasm	0.00186	0.00218	CcSEcCtD
Ciclesonide—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.00177	0.00208	CcSEcCtD
Ciclesonide—Infestation NOS—Etoposide—peripheral nervous system neoplasm	0.00176	0.00207	CcSEcCtD
Ciclesonide—Infestation—Etoposide—peripheral nervous system neoplasm	0.00176	0.00207	CcSEcCtD
Ciclesonide—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00176	0.00206	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00174	0.00205	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00203	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00203	CcSEcCtD
Ciclesonide—Ulcer—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00203	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00171	0.002	CcSEcCtD
Ciclesonide—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00171	0.002	CcSEcCtD
Ciclesonide—Back pain—Alitretinoin—peripheral nervous system neoplasm	0.00171	0.002	CcSEcCtD
Ciclesonide—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00199	CcSEcCtD
Ciclesonide—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00199	CcSEcCtD
Ciclesonide—Candida infection—Epirubicin—peripheral nervous system neoplasm	0.00168	0.00198	CcSEcCtD
Ciclesonide—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00168	0.00198	CcSEcCtD
Ciclesonide—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00167	0.00196	CcSEcCtD
Ciclesonide—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00167	0.00196	CcSEcCtD
Ciclesonide—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00167	0.00196	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00165	0.00194	CcSEcCtD
Ciclesonide—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00165	0.00194	CcSEcCtD
Ciclesonide—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00165	0.00194	CcSEcCtD
Ciclesonide—Back pain—Vincristine—peripheral nervous system neoplasm	0.00164	0.00193	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00164	0.00192	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00164	0.00192	CcSEcCtD
Ciclesonide—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00164	0.00192	CcSEcCtD
Ciclesonide—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00164	0.00192	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00162	0.0019	CcSEcCtD
Ciclesonide—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00162	0.0019	CcSEcCtD
Ciclesonide—Candida infection—Doxorubicin—peripheral nervous system neoplasm	0.00156	0.00183	CcSEcCtD
Ciclesonide—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.00156	0.00183	CcSEcCtD
Ciclesonide—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00183	CcSEcCtD
Ciclesonide—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00155	0.00182	CcSEcCtD
Ciclesonide—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00154	0.00181	CcSEcCtD
Ciclesonide—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.0018	CcSEcCtD
Ciclesonide—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00179	CcSEcCtD
Ciclesonide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00152	0.00178	CcSEcCtD
Ciclesonide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00151	0.00177	CcSEcCtD
Ciclesonide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00151	0.00177	CcSEcCtD
Ciclesonide—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00176	CcSEcCtD
Ciclesonide—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00176	CcSEcCtD
Ciclesonide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00149	0.00175	CcSEcCtD
Ciclesonide—Diabetes mellitus—Epirubicin—peripheral nervous system neoplasm	0.00147	0.00173	CcSEcCtD
Ciclesonide—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00172	CcSEcCtD
Ciclesonide—Hypertension—Vincristine—peripheral nervous system neoplasm	0.00147	0.00172	CcSEcCtD
Ciclesonide—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00143	0.00168	CcSEcCtD
Ciclesonide—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.00143	0.00168	CcSEcCtD
Ciclesonide—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00142	0.00167	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00141	0.00166	CcSEcCtD
Ciclesonide—Infection—Vincristine—peripheral nervous system neoplasm	0.00138	0.00162	CcSEcCtD
Ciclesonide—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00137	0.00161	CcSEcCtD
Ciclesonide—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.00136	0.0016	CcSEcCtD
Ciclesonide—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00136	0.0016	CcSEcCtD
Ciclesonide—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00136	0.0016	CcSEcCtD
Ciclesonide—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00135	0.00158	CcSEcCtD
Ciclesonide—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00134	0.00158	CcSEcCtD
Ciclesonide—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00134	0.00157	CcSEcCtD
Ciclesonide—Back pain—Etoposide—peripheral nervous system neoplasm	0.00133	0.00156	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00154	CcSEcCtD
Ciclesonide—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.0015	CcSEcCtD
Ciclesonide—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00128	0.0015	CcSEcCtD
Ciclesonide—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00149	CcSEcCtD
Ciclesonide—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00127	0.00148	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00126	0.00148	CcSEcCtD
Ciclesonide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00126	0.00147	CcSEcCtD
Ciclesonide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00126	0.00147	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00146	CcSEcCtD
Ciclesonide—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00146	CcSEcCtD
Ciclesonide—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00145	CcSEcCtD
Ciclesonide—Infection—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00143	CcSEcCtD
Ciclesonide—Rash—Topotecan—peripheral nervous system neoplasm	0.00121	0.00142	CcSEcCtD
Ciclesonide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00121	0.00141	CcSEcCtD
Ciclesonide—Cough—Etoposide—peripheral nervous system neoplasm	0.0012	0.00141	CcSEcCtD
Ciclesonide—Headache—Topotecan—peripheral nervous system neoplasm	0.0012	0.00141	CcSEcCtD
Ciclesonide—Rash—Tretinoin—peripheral nervous system neoplasm	0.0012	0.0014	CcSEcCtD
Ciclesonide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.0014	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.0012	0.0014	CcSEcCtD
Ciclesonide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0012	0.0014	CcSEcCtD
Ciclesonide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0012	0.0014	CcSEcCtD
Ciclesonide—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0012	0.0014	CcSEcCtD
Ciclesonide—Headache—Tretinoin—peripheral nervous system neoplasm	0.00119	0.0014	CcSEcCtD
Ciclesonide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00119	0.0014	CcSEcCtD
Ciclesonide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00119	0.00139	CcSEcCtD
Ciclesonide—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00139	CcSEcCtD
Ciclesonide—Rash—Melphalan—peripheral nervous system neoplasm	0.00118	0.00139	CcSEcCtD
Ciclesonide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00118	0.00138	CcSEcCtD
Ciclesonide—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00117	0.00137	CcSEcCtD
Ciclesonide—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00134	CcSEcCtD
Ciclesonide—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.00134	CcSEcCtD
Ciclesonide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00114	0.00134	CcSEcCtD
Ciclesonide—Nausea—Topotecan—peripheral nervous system neoplasm	0.00114	0.00133	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00133	CcSEcCtD
Ciclesonide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00132	CcSEcCtD
Ciclesonide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00132	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00131	CcSEcCtD
Ciclesonide—Infection—Etoposide—peripheral nervous system neoplasm	0.00112	0.00131	CcSEcCtD
Ciclesonide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00111	0.00131	CcSEcCtD
Ciclesonide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00111	0.00131	CcSEcCtD
Ciclesonide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.00111	0.0013	CcSEcCtD
Ciclesonide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00128	CcSEcCtD
Ciclesonide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00125	CcSEcCtD
Ciclesonide—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00124	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00124	CcSEcCtD
Ciclesonide—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00123	CcSEcCtD
Ciclesonide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00103	0.00121	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00121	CcSEcCtD
Ciclesonide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.0012	CcSEcCtD
Ciclesonide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00118	CcSEcCtD
Ciclesonide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.001	0.00117	CcSEcCtD
Ciclesonide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000995	0.00117	CcSEcCtD
Ciclesonide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000993	0.00116	CcSEcCtD
Ciclesonide—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000987	0.00116	CcSEcCtD
Ciclesonide—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000987	0.00116	CcSEcCtD
Ciclesonide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000985	0.00116	CcSEcCtD
Ciclesonide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000978	0.00115	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000969	0.00114	CcSEcCtD
Ciclesonide—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000968	0.00114	CcSEcCtD
Ciclesonide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000959	0.00113	CcSEcCtD
Ciclesonide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000959	0.00113	CcSEcCtD
Ciclesonide—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000952	0.00112	CcSEcCtD
Ciclesonide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000951	0.00112	CcSEcCtD
Ciclesonide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000932	0.00109	CcSEcCtD
Ciclesonide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000931	0.00109	CcSEcCtD
Ciclesonide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000926	0.00109	CcSEcCtD
Ciclesonide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000922	0.00108	CcSEcCtD
Ciclesonide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000918	0.00108	CcSEcCtD
Ciclesonide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000917	0.00108	CcSEcCtD
Ciclesonide—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000913	0.00107	CcSEcCtD
Ciclesonide—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000913	0.00107	CcSEcCtD
Ciclesonide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000907	0.00106	CcSEcCtD
Ciclesonide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000906	0.00106	CcSEcCtD
Ciclesonide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000901	0.00106	CcSEcCtD
Ciclesonide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000892	0.00105	CcSEcCtD
Ciclesonide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00089	0.00104	CcSEcCtD
Ciclesonide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000888	0.00104	CcSEcCtD
Ciclesonide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000888	0.00104	CcSEcCtD
Ciclesonide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000888	0.00104	CcSEcCtD
Ciclesonide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000886	0.00104	CcSEcCtD
Ciclesonide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000879	0.00103	CcSEcCtD
Ciclesonide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000879	0.00103	CcSEcCtD
Ciclesonide—Rash—Vincristine—peripheral nervous system neoplasm	0.000874	0.00103	CcSEcCtD
Ciclesonide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000873	0.00102	CcSEcCtD
Ciclesonide—Headache—Vincristine—peripheral nervous system neoplasm	0.000868	0.00102	CcSEcCtD
Ciclesonide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000861	0.00101	CcSEcCtD
Ciclesonide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.00101	CcSEcCtD
Ciclesonide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000854	0.001	CcSEcCtD
Ciclesonide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000824	0.000967	CcSEcCtD
Ciclesonide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000823	0.000966	CcSEcCtD
Ciclesonide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000822	0.000964	CcSEcCtD
Ciclesonide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00082	0.000962	CcSEcCtD
Ciclesonide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000814	0.000955	CcSEcCtD
Ciclesonide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000806	0.000945	CcSEcCtD
Ciclesonide—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.0008	0.000939	CcSEcCtD
Ciclesonide—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000798	0.000937	CcSEcCtD
Ciclesonide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000773	0.000907	CcSEcCtD
Ciclesonide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000772	0.000906	CcSEcCtD
Ciclesonide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000755	0.000886	CcSEcCtD
Ciclesonide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000746	0.000875	CcSEcCtD
Ciclesonide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000743	0.000871	CcSEcCtD
Ciclesonide—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.00074	0.000869	CcSEcCtD
Ciclesonide—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000739	0.000867	CcSEcCtD
Ciclesonide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000728	0.000854	CcSEcCtD
Ciclesonide—Rash—Etoposide—peripheral nervous system neoplasm	0.000708	0.000831	CcSEcCtD
Ciclesonide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000707	0.00083	CcSEcCtD
Ciclesonide—Headache—Etoposide—peripheral nervous system neoplasm	0.000703	0.000825	CcSEcCtD
Ciclesonide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000699	0.00082	CcSEcCtD
Ciclesonide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.00069	0.00081	CcSEcCtD
Ciclesonide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000682	0.0008	CcSEcCtD
Ciclesonide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000673	0.00079	CcSEcCtD
Ciclesonide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000667	0.000783	CcSEcCtD
Ciclesonide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000666	0.000781	CcSEcCtD
Ciclesonide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000657	0.00077	CcSEcCtD
Ciclesonide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000657	0.00077	CcSEcCtD
Ciclesonide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000642	0.000753	CcSEcCtD
Ciclesonide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000631	0.00074	CcSEcCtD
Ciclesonide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000625	0.000734	CcSEcCtD
Ciclesonide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.000731	CcSEcCtD
Ciclesonide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000616	0.000723	CcSEcCtD
Ciclesonide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000713	CcSEcCtD
Ciclesonide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000713	CcSEcCtD
Ciclesonide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000594	0.000697	CcSEcCtD
Ciclesonide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000579	0.000679	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000573	0.000673	CcSEcCtD
Ciclesonide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000561	0.000658	CcSEcCtD
Ciclesonide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000554	0.00065	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000638	CcSEcCtD
Ciclesonide—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000543	0.000637	CcSEcCtD
Ciclesonide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000531	0.000623	CcSEcCtD
Ciclesonide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000609	CcSEcCtD
Ciclesonide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000513	0.000602	CcSEcCtD
Ciclesonide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.00059	CcSEcCtD
Ciclesonide—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000589	CcSEcCtD
Ciclesonide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000587	CcSEcCtD
Ciclesonide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000463	0.000543	CcSEcCtD
Ciclesonide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000452	0.00053	CcSEcCtD
Ciclesonide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.00049	CcSEcCtD
Ciclesonide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000416	0.000488	CcSEcCtD
Ciclesonide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000466	CcSEcCtD
Ciclesonide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000465	CcSEcCtD
Ciclesonide—Headache—Epirubicin—peripheral nervous system neoplasm	0.000394	0.000463	CcSEcCtD
Ciclesonide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000385	0.000452	CcSEcCtD
Ciclesonide—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000381	0.332	CrCbGaD
Ciclesonide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000374	0.000439	CcSEcCtD
Ciclesonide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000431	CcSEcCtD
Ciclesonide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.00043	CcSEcCtD
Ciclesonide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000365	0.000428	CcSEcCtD
Ciclesonide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.000406	CcSEcCtD
Ciclesonide—Prednisone—ABCB1—peripheral nervous system neoplasm	0.000291	0.254	CrCbGaD
Ciclesonide—Prednisolone—ABCB1—peripheral nervous system neoplasm	0.000268	0.234	CrCbGaD
Ciclesonide—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	0.000205	0.179	CrCbGaD
